Biocircuits Corp., of Sunnyvale, Calif., received $3.5million from Beckman Instruments Inc., of Fullerton,Calif., which got certain options for licensing andmarketing rights to testing applications using Biocircuits'lipid/polymer technology in immunodiagnosticapplications. Separately, Biocircuits filed a 510 (k)premarket notification for a T4 assay for use in its IOSsystem to assess thyroid function.
Biomira Inc., of Edmonton, Alberta, said licenseeTosoh Corp., of Tokyo, received approval in Japan tomarket its CA 125 antigen automated in vitro diagnostickit for detection of the antigen in ovarian cancer patients.
International Murex Technologies Corp., of Atlanta, gotapproval of its 510(k) application to market itsStaphaurex Plus test kit, which is designed for thedetection of Staphylococcus aureus.
Vysis Inc., of Downers Grove, Ill., received a $2 millionU.S. Department of Commerce grant to develop a novelassay system for the simultaneous analysis of multiplegenetic and infectious disease targets.
* Biomerica Inc., of Newport Beach, Calif., grantedGeneral Injectables & Vaccines Inc., of Bastian, Va.,exclusive U.S. marketing rights to its EZ Detect StoolBlood Test.
* Inflazyme Pharmaceuticals Ltd., of Vancouver, BritishColumbia, was awarded a research grant from the WorldHealth Organization to conduct trials of its tuberculosisdiagnostic test lit in Uganda.
(c) 1997 American Health Consultants. All rights reserved.